Latest News About Glyphosate

Here’s the latest you asked for, based on recent coverage up to 2026.

• Key theme: renewed scrutiny of glyphosate's safety and regulatory status, driven by a high-profile retraction and ongoing litigation in the United States, with regulators facing renewed pressure to reassess risk assumptions. This includes debates over whether older studies underpinning safety conclusions remain valid.[1][3][4]
• Notable developments:
  • A landmark glyphosate safety paper was retracted in late 2025/early 2026 due to concerns about study provenance and ghostwriting, prompting calls for EPA and other regulators to reevaluate the risk profile of glyphosate-based products.[3][1]
  • The EPA has signaled that its evaluation of glyphosate does not rely solely on the retracted study and remains engaged in ongoing review processes, amid continued litigation and calls for more conservative safety standards.[2][1]
  • Public and NGO discussions emphasize broader exposure concerns, potential cancer links, and the need for independent data in risk assessments, with some groups urging temporary sales pauses or faster independent reviews while regulators reassess labeling and usage guidelines.[4][3]

Illustration of the current landscape:

• Regulatory stance: EPA ongoing review, with emphasis on multiple data sources beyond the retracted study.[1]
• Legal and industry dynamics: Litigation-driven pressure on manufacturers and regulators, including substantial Roundup-related settlements and ongoing court cases that influence public perception and policy.[2]

What this means for residents in Florida (including Miami):

• If regulatory reviews lead to stricter risk thresholds or labeling changes, usage guidelines at home, on farms, and in landscaping could tighten, affecting consumer products and agricultural practices in the state.[1][2]
• Local health discussions may increasingly cite exposure considerations for children and pregnant people, although official health agency positions may remain that glyphosate is safe when used as labeled, pending further regulator findings.[3]

If you’d like, I can pull the latest articles with direct quotes and summarize the stance of specific agencies (EPA, Health Canada, EU regulators) or compile a brief, citation-rich briefing tailored to Miami/Florida concerns. I can also provide a timeline of recent regulatory actions and key court milestones.